Immediately postoperatively, corneal graft displacement ... after the procedure the peripheral edema had completely resolved and the patients' subjective symptoms were improved.

In May 2023, results of a phase 2 study of 49 subjects with corneal edema were presented, showing faster visual recovery in the active treatment group (Baartman et al). Cells may be derived from ...

In this case report we present a patient with displaced donor graft after DSAEK and associated peripheral corneal edema that resolved without any further intervention three months postoperatively.

Recognising symmetrical corneal thinning as an early manifestation of ICE syndrome may enable earlier diagnosis and management of patients with the disease, reducing signs and symptoms of disease ...

an allogeneic cell therapy product candidate for the treatment of corneal edema secondary to corneal endothelial dysfunction. AURN001 is a combination cell therapy product candidate comprised of ...

Vyznova is under clinical development by Aurion Biotechnologies and currently in Phase II for Corneal Edema. According to GlobalData, Phase II drugs for Corneal Edema does not have sufficient ...